Objective: To examine trends in ambulatory care utilization when individuals face almost no fi nancial barriers to health care.
Between 1997 and 2002, health care costs in Switzerland increased from 38 670 to 47 959 millions CHF (Offi ce fédéral de la santé publique 2004). This steady rise in annual health care costs brings Switzerland to rank second, after the United States, in terms of health spending (Organization for Economic Co-operation and Development (OECD) 2004). Several explanations to rising health expenditures were explored by Bodenheimer in a series of articles (Bodenheimer 2005a; Bodenheimer 2005b; Bodenheimer 2005c) , including factors external to the health care system such as aging of the population or the state of the overall economy, technologic innovation and the market power of health care providers. He concluded that rising health care costs in the United States were not strongly associated with the aging demographic trend of the population, but that the market power of healthcare providers, and even more technologic advances, were key drivers of this growth. In Switzerland, politicians explicitly attributed part of the rise in health spending to the increase in physicians' density, which reached 1.96/1 000 inhabitants in 2002, and passed a federal urgent act forbidding the opening of new private practices in July 2002. Patients' expectations and demand for health care may possibly lead to increased utilization (Domenighetti & Pipitone 2002) , especially if health care access is facilitated by a regular rise in physicians' density. We hypothesized that persons most likely to intensify their health care utilization would be those whose health insurance deductible was minimal, therefore guarantying almost no financial barriers to health care. We were primarily interested in looking whether these insurees modifi ed their health care utilization over time and consulted more as medical density increased. Of particular interest was the pattern of the rise in ambulatory care costs, namely whether insurees used more ambulatory care in terms of number of medical visits or of visits intensity (more prescribed services and/or drugs), and whether the proportion of ambulatory care visits to generalists, internists, other specialists and hospital outpatients services changed over time. We hence conducted an observational study of Swiss insurance data to evaluate time trends in ambulatory care over the 1997-2002 period.
Methods

Setting and Study Population
In Switzerland, a country of 7.3 million inhabitants, ambulatory care is mainly provided by independent private practi-tioners and outpatient services located in hospitals, paid on a fee-for-service basis. Since the new Health Insurance Law came into force in January 1996, greater social solidarity and universal access to health care has been achieved through compulsory basic health insurance coverage that includes a comprehensive package of health benefi ts identical for all insurees (Polikowski & Santos-Eggimann 2002) . By law, a fi nite set of contracts vary essentially by the level of annual deductible, with higher deductibles being associated with lower monthly premiums. Beyond the selected deductible, all insurees contribute to 10 % of ambulatory costs, up to an annual ceiling. Anonymous health insurance data were obtained from one of the four largest Swiss health insurance companies, from 1997 to 2002, time period for which data were available. Included were all adults aged > 19 years having chosen a minimal deductible (150.-Swiss francs in 1997 deductible (150.-Swiss francs in , 230.-in 1998 deductible (150.-Swiss francs in -2002 . Excluded were insurees with HMO contracts (selected by 1.5 %-3.2 % each year) and those not insured during the whole fi scal year (approximately 1 % of insurees). Insurees with higher deductibles health plans (29-33 % of insurees) were not included in the dataset since they faced additional fi nancial barriers to health care access.
Measures
Ambulatory care utilization dimensions of main interest were ambulatory care visits and costs. Insurees who had total ambulatory care costs below the annual deductible or who did not send their bills to the health plan were counted as having neither ambulatory care costs nor visits.
Ambulatory care visits
Ambulatory care visits were counted only if the encounter included a contact with a physician, and categorized as visits to: generalists, internists, other specialists and any physician from hospital outpatient services (specialty unknown).
Ambulatory care costs
Total ambulatory care costs were defi ned as all costs associated with ambulatory or outpatient medical consultations, including laboratory, radiology and other complementary exams and ambulatory prescribed drugs. They were divided into services costs and drug costs, the latter incorporating only the costs of prescribed drugs. Services and drug costs could not be divided into smaller components such as laboratory or radiology costs, for example. For each year, the mean costs per ambulatory care visit was calculated by dividing the total ambulatory care costs by the total number of ambulatory care visits. Costs billed by health professionals were expressed in Swiss francs. Because medical care infl ation rate was low (yearly variations approximated 0.5 % between 1997 to 2002), we did not adjust costs for infl ation.
Other variables
Demographic characteristics (age and sex) as well as selected events (hospitalization and death during the current year) were obtained from the health plan administrative data. Socio-economic variables and comorbidities were not available.
Statistical Analysis
Based on yearly cross-sectional analysis, simple descriptive statistics were used. We chose not to report P-values describing ambulatory care utilization over time because the large number of patients included result in even minor differences being statistically signifi cant. We rather emphasized possible relevance of the results.
Results
Demographics of the study population did not change markedly during the observed period. The proportion of female insurees slightly increased, from 55.8 % in 1997 to 57.0 % in 2002. Mean age fl uctuated between 48.3y (19.6 SD) and 49.5y (19.8 SD), and death rates varied from 140/10 000 (1998) to 151/10 000 (1997 and 2002) . The proportion of insurees having had any health care cost (ambulatory and/or hospital) regularly increased, from 74.7 % (1997) to 80.0 % (2002) , and the proportion of any hospital admission remained pretty stable (Tab. 1).
Trends in ambulatory care visits
The yearly mean number of ambulatory care visits per insuree increased slightly throughout the years, as the proportion of insurees having had no visits during the year declined while the proportion of those with seven or more visits increased. Also, the distribution of ambulatory care visits by type of providers showed a small change with fewer visits to generalists (from 45.8 % in 1997 to 44.1 % in 2002) but more consultations to hospital outpatient services (from 6.3 % in 1997 to 8.7 % in 2002). The proportion of visits to internists and specialists remained constant (Tab. 1).
Trends in ambulatory care costs
Mean total ambulatory care costs per insuree increased from 1 292.-(1997) to 1 790.-CHF (2002, +38.5 %). Graphic 1 displays this rise, mostly refl ecting an increase in drug costs (+61.7 %) and to a lesser extent an increase in services costs (+24.3 %). It also shows the proportional annual growth in those 2 components, as well as the regular augmentation in mean cost per ambulatory care visit.
Discussion
This study explored patterns and trends of ambulatory care utilization of patients with almost no fi nancial barriers to health care. In a demographically stable population of insurees, ambulatory care utilization was characterized by an increase in ambulatory care costs which was primarily due neither to a growth in the volume of physicians visits nor to an increase in physicians fees. Rather, the increase was essentially due to what was included in or prescribed during physicians' visits, particularly prescribed ambulatory care drugs. Unfortunately, whether the latter represented a higher number of drugs and/ or more expensive drugs prescribed remained unknown.
A complete data set of all insurees with minimal annual deductible from a sizeable insurance company, the large sample size and the availability of individual level data devoid of recall bias are important strengths of this study. However, some limitations have to be considered. Firstly, due to the scarcity of Swiss health care data and because little has been published on Swiss ambulatory care utilization (Etter & Perneger 1997; Jeangros et al. 1999; Schellhorn et al. 2000; Martin et al. 1981) , trends in utilization and costs components are diffi cult to analyze more precisely. Nonetheless, compared to the usually used aggregated data, we had additional information on the number of physicians encounters and the type of providers seen. Secondly, insurees who had annual health care costs below the minimal deductible were considered to have no utilization if they did not send their bills to the health insurance plan. As the minimal deductible was low, underestimation of ambulatory care utilization was minor. In addition, hospitalization and medical visit fi gures similar to ours were described in the 2002 Swiss Health Survey (Offi ce fédéral de la statistique 2003). Finally, we cannot ascertain generalization of our results to the Swiss population having minimal annual deductible, as we do not know how similar other health plans insurees are to the insurees included in this study. Nevertheless, the health insurance company considered is one of the four major Swiss health insurance companies with a yearly number of insurees of 1 million, and its insurees and the Swiss population show very close age-sex compositions. Growth in ambulatory care costs in Switzerland (Sturny 2004) , can be due to increases in the price, volume or change of mix of prescribed drugs and/or services, or in a combination of them. Drug prices, that rose by 48 % from 1998 to 2003 (Santésuisse 2004 ) could explain part of that growth, while in contrast, prices of other medical inputs (physicians' fees, charges for X-rays, laboratory tests, …) did not significantly change during those years and medical care infl ation remained modest. According to our data, the progression of the volume of ambulatory care visits was marginal and was unlikely to explain rising ambulatory health care costs. However, the volume of what was included in or prescribed during a physician's visit increased, and the type of providers visited changed, which may both have contributed to the evolution of costs. A higher number of drugs prescribed could also be a possibility. Unfortunately, a change in the mix of prescription of drugs or services cannot be excluded or confi rmed due to the limitations of our data set, but more prescriptions of services and drugs is likely in a context of continuing development of medical care technology, expending choices and recent changes in drug therapy and/or therapeutic aggressiveness. Aging of the population as a possible major cause for the continuing rise in ambulatory care consumption in our sample may be wisely ruled out as it was demographically stable. Increased physicians' density could result in rising demand from patients (Domenighetti & Pipitone 2002) , even more if they face little barriers to health care, or in physician-induced demand, especially in a system of fee-for-service payment shown to be a predictor of health care utilization (Greenfi eld et al. 1992) . Results of physician-induced demand studies are inconsistent. In Switzerland, despite the existence of crosssectional associations between physicians' density and health care costs (Domenighetti 1998; Domenighetti & Casabianca 1995) , variations in costs do not seem to be correlated to physicians' density (Abrahamsen et al. 2005; Horisberger et al. 2004) . Technologic advances and innovation, which spread largely and are usually associated with increased costs (Bodenheimer 2005b) , are very likely to be also responsible for part of the growth in Swiss health spending in a period of low variation in the volume of ambulatory care consultations. In conclusion, information on time trends in ambulatory care can improve our understanding of that component of the health care system. It may also assist in the formulation of health policies related to ambulatory care. In the future, it should however be combined to more detailed systematic data collection. In the meantime, in a health care system that abruptly institutes new regulations, available data should be used. They actually allow us to detect ambulatory care trends: the intensifi cation of ambulatory care visits, not in terms of number of visits but of what is subsequent to them, should be looked upon more carefully. 
